Monday, July 20, 2009

Risk Factors for FIV Infection

Murray, J.K., et al., Risk factors for feline immunodeficiency virus antibody test status in Cats Protection adoption centres (2004). Journal of Feline Medicine & Surgery, 2009. 11(6): p. 467-473.

This study determined the prevalence of feline immunodeficiency virus (FIV) within a group of cats entering 10 United Kingdom adoption centres run by Cat Protection. All cats entering the facilities were tested for FIV using a rapid enzyme immunoassay antibody test. The overall prevalence of positive test results was 3.1%, while the prevalence at different adoption centres varied from 0.8% to 6.7%. Male cats were found to be approximately three times more likely than female cats to be FIV positive. The previous history of the cat was also shown to be associated with FIV status, where cats admitted from stray or feral backgrounds were approximately three times more likely to be FIV positive than those cats surrendered by their owners. Cats in poor health were four times more likely to be positive than those with fair to good health. There was no evidence found for an association between neuter status and FIV test results. The study may help adoption centres identify those cats with an increased risk of FIV for routine FIV testing. [VT]
>> PubMed Abstract

Related articles:
Levy, J.K., et al., Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity. J Am Vet Med Assoc, 2006. 228(3): p. 371-6.
>> PubMed Abstract

Macieira, D.B., et al., Prevalence and risk factors for hemoplasmas in domestic cats naturally infected with feline immunodeficiency virus and/or feline leukemia virus in Rio de Janeiro - Brazil. J Feline Med Surg, 2008. 10(2): p. 120-9.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library
Join us on Facebook

Friday, July 17, 2009

Treatment of Feline Diabetes with Diet and Insulin

Hall, T. D., O. Mahony, et al. (2009). "Effects of diet on glucose control in cats with diabetes mellitus treated with twice daily insulin glargine." Journal of Feline Medicine & Surgery 11(2): 125-130.

Diabetes mellitus is a common feline disease and is treated with a combination of dietary therapy and insulin. Insulin glargine (Lantus, Sanofi-Aventis) is a long-acting recombinant human insulin that is frequently used to treat diabetic cats. The purpose of this study, from Tufts Cummings School of Veterinary Medicine, was to compare a low carbohydrate/high protein (LCHP) diet to a non-prescription control diet in diabetic cats receiving insulin glargine twice daily. Over the 10-week trial, 6 cats were given the LCHP diet (DM Dietetic Management Feline Formula dry & canned, Nestle Purina) and 6 cats were given control diets (Pro Plan Adult Cat total Care Chicken and Rice dry, Nestle Purina and Friskies Special Diet Turkey & Giblets Dinner canned, Nestle Purina). Re-evaluations (blood glucose curves, serum fructosamine, and assessment of clinical signs) were performed at weeks 1, 2, 4, 6, and 10. Using insulin glargine twice daily and frequent monitoring, all cats in both groups did well. The main difference between the two groups was that the cats fed the LCHP diet had significantly lower serum fructosamine levels compared to the cats on the control diets. The clinical significance of this is unknown as all cats in both diet groups achieved good glycemic control. [SL]
>> PubMed Abstract

Related articles:
Marshall, R. D., J. S. Rand, et al. (2008). "Glargine and protamine zinc insulin have a longer duration of action and result in lower mean daily glucose concentrations than lente insulin in healthy cats." J Vet Pharmacol Ther 31(3): 205-212.
>> PubMed Abstract

Rios, L. and C. Ward (2008). "Feline diabetes mellitus: diagnosis, treatment, and monitoring." Compend Contin Educ Vet 30(12): 626-39; quiz 639-40.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library
Join us on Facebook

Wednesday, July 15, 2009

Feline Papillomavirus

Munday, J. S., L. Howe, et al. (2008). "Detection of papillomaviral DNA sequences in a feline oral squamous cell carcinoma." Res Vet Sci 86(2): 359-361.

Oral squamous cell carcinomas constitute 7.5% of all feline cancers, and often lead to death in affected cats. In humans, these tumors are associated with papillomavirus in about 25% of the cases. To investigate the association of papillomavirus with feline oral tumors, 40 oral lesions (20 cancerous, 20 non-cancerous) were examined for viral DNA. Papillomaviral DNA was detected in one oral tumor, but not in any non-cancerous lesion. Finding viral DNA in only one tumor did not indicate a causal relationship. The finding of viral DNA does however indicate additional research into the carcinogenic potential of these viruses in cats is warranted; the carcinogenic potential of papillomaviruses in general and the finding here of viral DNA in a feline oral tumor hints at a possible role. [MK]
>> PubMed Abstract

Related articles:
Munday, J. S., M. Kiupel, et al. (2007). "Detection of papillomaviral sequences in feline Bowenoid in situ carcinoma using consensus primers." Vet Dermatol 18(4): 241-5.
>> PubMed Abstract

Sundberg, J., M. Van Ranst, et al. (2000). "Feline papillomas and papillomaviruses." Vet Pathol 37(1): 1-10.
>> PubMed Abstact

More on cat health: Winn Feline Foundation Library
Join us on Facebook